| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.756 | - | 12.946 | - | - | 8.132 | 9.125 | 14.012 | 41.941 | 22.035 |
| Total Income - EUR | 26.820 | - | 13.032 | - | - | 8.204 | 9.187 | 14.081 | 41.990 | 22.042 |
| Total Expenses - EUR | 23.206 | - | 13.581 | - | - | 10.658 | 11.807 | 10.324 | 32.592 | 23.199 |
| Gross Profit/Loss - EUR | 3.614 | - | -549 | - | - | -2.454 | -2.620 | 3.756 | 9.398 | -1.156 |
| Net Profit/Loss - EUR | 2.822 | - | -940 | - | - | -2.688 | -2.896 | 3.433 | 7.779 | -1.404 |
| Employees | 0 | - | 1 | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Schwartz Bio Consult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.298 | - | 1.055 | - | - | 463 | 282 | 134 | 14 | 0 |
| Current Assets | 24.519 | - | 21.158 | - | - | 26.208 | 23.640 | 26.022 | 35.142 | 24.457 |
| Inventories | 344 | - | 543 | - | - | 971 | 1.292 | 1.412 | 35 | 35 |
| Receivables | 9.334 | - | 3.436 | - | - | 4.329 | 3.370 | 3.698 | 12.427 | 4.029 |
| Cash | 14.841 | - | 17.179 | - | - | 20.908 | 18.978 | 20.913 | 22.681 | 20.393 |
| Shareholders Funds | 21.488 | - | 17.210 | - | - | 19.104 | 15.785 | 19.243 | 26.964 | 12.785 |
| Social Capital | 45 | - | 44 | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.344 | - | 5.021 | - | - | 7.588 | 8.158 | 6.934 | 8.213 | 11.692 |
| Income in Advance | 0 | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Schwartz Bio Consult S.r.l.